Katherine Kalin
Vermögen: 1 Mio $ am 31.05.2026
Vermögen: 1 Mio $ am 31.05.2026
Katherine Bach Kalin is currently Director at Brown Advisory, Inc. since 2018, Independent Director at Genfit SA since 2020, Independent Director at SELLAS Life Sciences Group, Inc. since 2022, and Trustee at Summit Foundation.
Former roles include Independent Director at Athersys, Inc. from 2020 to 2022, Director at Clinical Genomics Technologies Pty Ltd. from 2018 to 2021, Vice President at Celgene Corp.
from 2012 to 2017, Finance Manager at Nomura International Plc and Nomura International Ltd. from 1984 to 1988, and Partner at Mckinsey & Co. SAS from 1990 to 2002.
Education includes an undergraduate degree from the University of Durham and an MBA from Harvard Business School.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 15.04.2026 | 104’400 ( 0.06% ) | 971 964 $ | 31.05.2026 | |
GENFIT SA 0.01% | 01.04.2025 | 5’000 ( 0.01% ) | 51 346 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| GENFIT | Direktor/Vorstandsmitglied | 07.07.2020 |
| SELLAS LIFE SCIENCES GROUP, INC. | Direktor/Vorstandsmitglied | 13.08.2022 |
Brown Advisory, Inc.
Brown Advisory, Inc. Financial ConglomeratesFinance Provides investment services | Direktor/Vorstandsmitglied | 01.01.2018 |
Summit Foundation | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
| ATHERSYS, INC. | Direktor/Vorstandsmitglied | 16.06.2022 |
Clinical Genomics Technologies Pty Ltd.
Clinical Genomics Technologies Pty Ltd. Medical/Nursing ServicesHealth Services Provides colorectal cancer screening and monitoring services | Direktor/Vorstandsmitglied | 01.01.2021 |
| CELGENE | Corporate Officer/Principal | 01.09.2017 |
Mckinsey & Co. SAS
Mckinsey & Co. SAS Miscellaneous Commercial ServicesCommercial Services Provides business and management consulting services | Corporate Officer/Principal | 01.01.2002 |
Nomura International Plc
Nomura International Plc Investment Banks/BrokersFinance Provides brokerage services | Finanzdirektor/CFO | 01.01.1988 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 12 |
|---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Nomura International Plc
Nomura International Plc Investment Banks/BrokersFinance Provides brokerage services | Finance |
Brown Advisory, Inc.
Brown Advisory, Inc. Financial ConglomeratesFinance Provides investment services | Finance |
Summit Foundation | |
University of Durham
University of Durham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Genfit SA
Genfit SA BiotechnologyHealth Technology Engages in research and development of medicines and diagnostic solutions | Health Technology |
Nomura International Ltd.
Nomura International Ltd. Investment ManagersFinance Operates a holding company with interests in financial services businesses | Finance |
Athersys, Inc.
Athersys, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops novel and proprietary therapies | Health Technology |
Mckinsey & Co. SAS
Mckinsey & Co. SAS Miscellaneous Commercial ServicesCommercial Services Provides business and management consulting services | Commercial Services |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clinical Genomics Technologies Pty Ltd.
Clinical Genomics Technologies Pty Ltd. Medical/Nursing ServicesHealth Services Provides colorectal cancer screening and monitoring services | Health Services |
SELLAS Life Sciences Group, Inc.
SELLAS Life Sciences Group, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen